- Home
- BPMC vs MTDR Comparison
BPMC vs MTDR Comparison
Compare BPMC & MTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- MTDR
- Stock Information
- Founded
- BPMC 2008
- MTDR 2003
- Country
- BPMC United States
- MTDR United States
- Employees
- BPMC N/A
- MTDR N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- MTDR Oil & Gas Production
- Sector
- BPMC Health Care
- MTDR Energy
- Exchange
- BPMC Nasdaq
- MTDR Nasdaq
- Market Cap
- BPMC 5.9B
- MTDR 7.1B
- IPO Year
- BPMC 2015
- MTDR 2012
- Fundamental
- Price
- BPMC $90.14
- MTDR $53.11
- Analyst Decision
- BPMC Buy
- MTDR Strong Buy
- Analyst Count
- BPMC 20
- MTDR 14
- Target Price
- BPMC $120.79
- MTDR $74.69
- AVG Volume (30 Days)
- BPMC 667.8K
- MTDR 1.1M
- Earning Date
- BPMC 02-13-2025
- MTDR 02-18-2025
- Dividend Yield
- BPMC N/A
- MTDR 1.88%
- EPS Growth
- BPMC N/A
- MTDR 7.36
- EPS
- BPMC N/A
- MTDR 7.55
- Revenue
- BPMC $434,415,000.00
- MTDR $3,099,645,000.00
- Revenue This Year
- BPMC $108.09
- MTDR $34.10
- Revenue Next Year
- BPMC $39.34
- MTDR $19.49
- P/E Ratio
- BPMC N/A
- MTDR $7.03
- Revenue Growth
- BPMC 100.93
- MTDR 23.82
- 52 Week Low
- BPMC $72.24
- MTDR $47.15
- 52 Week High
- BPMC $121.90
- MTDR $71.08
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- MTDR 35.13
- Support Level
- BPMC $86.02
- MTDR $55.86
- Resistance Level
- BPMC $98.41
- MTDR $56.14
- Average True Range (ATR)
- BPMC 3.28
- MTDR 1.74
- MACD
- BPMC -0.76
- MTDR -0.71
- Stochastic Oscillator
- BPMC 33.04
- MTDR 1.15
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About MTDR Matador Resources Company
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business.